CorMatrix Cardiovascular Completes Enrollment Of Patients In RESTORE, First-In-Human Study With Cormatrix For Improvement Of Myocardial Function

WARSAW, Poland--(BUSINESS WIRE)--CorMatrix Cardiovascular Inc. of Roswell, Georgia and the Central Clinical Hospital of the Ministry of Interior in Warsaw (Centralny Szpital Kliniczny MSW) of Warsaw, Poland announced the successful enrollment and treatment of 5 patients in the first ever study evaluating the CorMatrix ECM delivered trans-epicardially for the improvement of myocardial function in patients at risk or suffering from congestive heart failure (CHF).

Help employers find you! Check out all the jobs and post your resume.